SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,944.28 -12.99
( -0.02%)

Global Indices

Nasdaq

53,227.35 -353.64
(-0.66%)

Dow Jones

7,711.10 -21.66
(-0.28%)

Hang Seng

66,431.13 119.20
(0.18%)

Nikkei 225

10,792.77 -31.49
(-0.29%)

Forex

USD-INR

95.47 -0.01
(-0.01%)

EUR-INR

110.57 -0.67
(-0.60%)

GBP-INR

129.19 -0.55
(-0.42%)

JPY-INR

0.60 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Venus Remedies Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

526953

INE411B01019

515.9180123

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VENUSREM

19.64

2221.86

EPS(TTM)

Face Value()

Div & Yield %

84.64

0.6

Back

Generic Engineering Construction & Projects standalone net profit rises 35.16% in the December 2025 quarter

Feb 15,2026

Net profit of Generic Engineering Construction & Projects rose 35.16% to Rs 2.46 crore in the quarter ended December 2025 as against Rs 1.82 crore during the previous quarter ended December 2024. Sales declined 13.61% to Rs 80.59 crore in the quarter ended December 2025 as against Rs 93.29 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	80.59	93.29	-14
OPM %	12.35	8.66	-
PBDT	7.73	6.21	24
PBT	4.26	3.02	41
NP	2.46	1.82	35

76,944.28 -12.99 ( -0.02%)

53,227.35 -353.64 (-0.66%)

7,711.10 -21.66 (-0.28%)

66,431.13 119.20 (0.18%)

10,792.77 -31.49 (-0.29%)

95.47 -0.01 (-0.01%)

110.57 -0.67 (-0.60%)

129.19 -0.55 (-0.42%)

0.60 0.00 (-0.48%)